Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim, Heena Olalde, Kathleen Mays-Wilson et al.|The Lancet Neurology|2019

Cited by 249